Catalyst Wire Dossier Catalyst Wire Dossier

Alferon LDO (Low Dose Oral)

interferon alfa-N3 · AIM ImmunoTech Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alferon LDO (Low Dose Oral), covering 2013-04-17 to 2013-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers [Phase 2]

See pricing